Smiles
O=C(NN1CC2CCCC2C1)NS(=O)(C3=C([2H])C([2H])=C(C)C([2H])=C3[2H])=O
Therapeutic Uses
Anti-Diabetic
Storage Condition
Store at freezer (-20°C) for long term storage
IUPAC Name
3-(3,3a,4,5,6,6a-Hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-1-(2,3,5,6-tetradeuterio-4-methylphenyl)sulfonylurea
References
"Duhault; J,; et al,: Arzneimittel-Forch,; 22; 1686 (1972); Holmes; B,; et al,: Drugs; 27; 301 (1984);"
Application Notes
"Labeled Gliclazide, intended for use as an internal standard for the quantification of Gliclazide by GC- or LC-mass spectrometry."
Purity by HPLC
Not less than 95%
Hazard Compound
Refer MSDS for accurate information
"Labeled Gliclazide, intended for use as an internal standard for the quantification of Gliclazide by GC- or LC-mass spectrometry."
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Gliclazide-d4 usage and description
Gliclazide D4 is a deuterated form of the oral anti-diabetic medication, Gliclazide. It is used in the treatment of type 2 diabetes mellitus, a condition that arises due to the body's inability to produce or effectively use insulin. Gliclazide D4 is specifically designed for use in research studies, including pharmacokinetic and pharmacodynamic studies, where the use of deuterated compounds is necessary for accurate analysis.
The chemical formula for Gliclazide D4 is C15H9D4N3O3S, and it has a molecular weight of 329.43 g/mol. The deuterated form of Gliclazide is created by replacing four hydrogen atoms with deuterium atoms, which are isotopes of hydrogen with a slightly higher mass. This modification does not change the therapeutic effects or mechanism of action of the medication, but it does allow for more precise determination of drug concentrations in biological samples.
Gliclazide D4 works by stimulating the pancreas to release insulin, which helps to lower blood sugar levels. It does this by binding to specific receptors on the beta cells of the pancreas, which triggers the release of insulin. Gliclazide D4 is typically administered orally, and its effects can last for up to 24 hours.
In conclusion, Gliclazide D4 is a deuterated form of the oral anti-diabetic medication, Gliclazide, which is used in research studies for accurate analysis. Its chemical formula is C15H9D4N3O3S, and it works by stimulating the pancreas to release insulin. Gliclazide D4 is a valuable tool for researchers studying the pharmacokinetics and pharmacodynamics of anti-diabetic medications.
